The following is the transcript of the interview with former FDA Commissioner Scott Gottlieb, who is on boards the of Pfizer ...
Senior Fellow Scott Gottlieb discusses the rapid expansion of CAR-T therapies, the implications of the new Psychedelics Executive Order, and efforts to streamline FDA approvals for next-gen treatments ...
How will the resignation of FDA Commissioner Marty Makary affect the Trump administration's health agenda? Former FDA Commissioner Scott Gottlieb weighs in.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results